ReP USP - Resultado da busca

Filtros : "REGULAÇÃO GÊNICA" "Financiamento CIHR" Removido: "Financiado pela Engineering and Physical Sciences Research Council(EPSRC-UK)" Limpar

Filtros

Autores USP
- braga, eliane candiani arantes (1)
- campos, juliane cruz (1)
- castro, michele mazzaron de (1)
- fazan júnior, rubens (1)
- ferreira, julio cesar batista (1)

Indexado em
- indexado no: biological sciences (1)
- indexado no: current contents (1)
- indexado no: medline (1)
- indexado no: pubmed (1)
- indexado no: scopus (1)

Colaboração institucional
Afiliação dos autores externos normalizada
Afiliação dos autores externos não normalizada
- bioinformatics core, harvard school of public health, harvard medical school, boston, ma, usa (1)
- department of biochemistry, medical sciences building, university of alberta, edmonton (1)
- department of food science and engineering, school of agriculture and biology, shanghai jiao tong university, shanghai, china (1)
- departments of pediatrics and pharmacology, university of alberta, mazankowski alberta heart institute, heritage medical research center, edmonton (1)
- division of experimental medicine, department of medicine, mcgill university, montreal, qc, canada (1)

Artigo de periodico
Mild mitochondrial impairment enhances innate immunity and longevity through ATFS-1 and p38 signaling (2021)
Campos, Juliane Cruz ; Wu, Ziyun ; Rudich, Paige ; Soo, Sonja K.; Mistry, Meeta ; Ferreira, Julio Cesar Batista ; Blackwell, T. Keith ; Raamsdonk, Jeremy M. Van
Fonte: EMBO Reports. Unidade: ICB
Assuntos: ANATOMIA, NEMATOIDES, MITOCÔNDRIAS, ENVELHECIMENTO, IMUNIDADE, PROTEÍNAS, ELÉTRONS, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Juliane Cruz et al. Mild mitochondrial impairment enhances innate immunity and longevity through ATFS-1 and p38 signaling. EMBO Reports, p. 1-19, 2021Tradução . . Disponível em: https://doi.org/10.15252/embr.202152964. Acesso em: 27 nov. 2025.
APA
Campos, J. C., Wu, Z., Rudich, P., Soo, S. K., Mistry, M., Ferreira, J. C. B., et al. (2021). Mild mitochondrial impairment enhances innate immunity and longevity through ATFS-1 and p38 signaling. EMBO Reports, 1-19. doi:10.15252/embr.202152964
NLM
Campos JC, Wu Z, Rudich P, Soo SK, Mistry M, Ferreira JCB, Blackwell TK, Raamsdonk JMV. Mild mitochondrial impairment enhances innate immunity and longevity through ATFS-1 and p38 signaling [Internet]. EMBO Reports. 2021 ; 1-19.[citado 2025 nov. 27 ] Available from: https://doi.org/10.15252/embr.202152964
Vancouver
Campos JC, Wu Z, Rudich P, Soo SK, Mistry M, Ferreira JCB, Blackwell TK, Raamsdonk JMV. Mild mitochondrial impairment enhances innate immunity and longevity through ATFS-1 and p38 signaling [Internet]. EMBO Reports. 2021 ; 1-19.[citado 2025 nov. 27 ] Available from: https://doi.org/10.15252/embr.202152964
Artigo de periodico
MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin (2021)
Parente, Juliana Montenegro; Mello, Marcela Maria Blascke de ; Silva, Pedro Henrique Leite da; Omoto, Ana Carolina Mieko ; Pernomian, Laena; Oliveira, Isadora Sousa de; Mahmud, Zabed; Júnior, Rubens Fazan ; Arantes, Eliane Candiani ; Schulz, Richard; Castro, Michele Mazzaron de
Fonte: Biochemical Pharmacology. Unidades: FMRP, FCFRP
Assuntos: HIPERTROFIA VENTRICULAR ESQUERDA, ANTIBIÓTICOS, REGULAÇÃO GÊNICA, HIPERTENSÃO, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARENTE, Juliana Montenegro et al. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin. Biochemical Pharmacology, v. 193, p. 1-13, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2021.114744. Acesso em: 27 nov. 2025.
APA
Parente, J. M., Mello, M. M. B. de, Silva, P. H. L. da, Omoto, A. C. M., Pernomian, L., Oliveira, I. S. de, et al. (2021). MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin. Biochemical Pharmacology, 193, 1-13. doi:10.1016/j.bcp.2021.114744
NLM
Parente JM, Mello MMB de, Silva PHL da, Omoto ACM, Pernomian L, Oliveira IS de, Mahmud Z, Júnior RF, Arantes EC, Schulz R, Castro MM de. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin [Internet]. Biochemical Pharmacology. 2021 ; 193 1-13.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.bcp.2021.114744
Vancouver
Parente JM, Mello MMB de, Silva PHL da, Omoto ACM, Pernomian L, Oliveira IS de, Mahmud Z, Júnior RF, Arantes EC, Schulz R, Castro MM de. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin [Internet]. Biochemical Pharmacology. 2021 ; 193 1-13.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1016/j.bcp.2021.114744

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo 2012 - 2025